Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

HealthCor Management LP Increases Stake In Clovis Oncology, Inc. (CLVS)

Page 1 of 15

Arthur B Cohen and Joseph Healey‘s HealthCor Management has filed a 13G with the Securities and Exchange Commission, disclosing its position in Clovis Oncology Inc (NASDAQ:CLVS). The filing showed that Healthcor owns 2.0 million shares of Clovis Oncology, which represent around 5.21% of the company’s outstanding common stock. This compares with the position of 1.53 million shares of Clovis that HealthCor reported in its 13F filing for the end of the last quarter. The fund initiated the position during the last three months of 2015.

However, Clovis Oncology has experienced a decrease in support from the world’s most elite money managers in the fourth quarter. At Q4’s end, a total of 24 of the hedge funds tracked by Insider Monkey held long positions in this stock, down by seven funds over the quarter. When looking at the institutional investors followed by Insider Monkey, Palo Alto Investors, managed by William Leland Edwards, holds the number one position in Clovis Oncology Inc (NASDAQ:CLVS), valued at $124.2 million at the end of 2015. The second largest stake is held by Point State Capital, led by Zach Schreiber, with a $122.6 million position.

Because Clovis Oncology Inc (NASDAQ:CLVS) has witnessed a declination in interest from the smart money, it’s safe to say that there were a few hedge funds that decided to sell off their entire stakes in the third quarter. Interestingly, Andreas Halvorsen’s Viking Global sold off the largest position of all the hedgies followed by Insider Monkey, comprising close to $76.9 million in stock, and Julian Baker and Felix Baker’s Baker Bros. Advisors was right behind this move, as the fund sold off about $18.6 million worth of shares.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
HealthCor Management 0 2,000,000 0 2,000,000 2,000,000 5.21%
HealthCor Associates 0 2,000,000 0 2,000,000 2,000,000 5.21%
HealthCor Offshore Master Fund 0 1,371,065 0 1,371,065 1,371,065 3.57%
HealthCor Offshore GP 0 1,371,065 0 1,371,065 1,371,065 3.57%
HealthCor Group 0 2,000,000 0 2,000,000 2,000,000 5.21%
Arthur Cohen 0 2,000,000 0 2,000,000 2,000,000 5.21%
Joseph Healey 0 2,000,000 0 2,000,000 2,000,000 5.21%
HealthCor Sanatate Offshore Master Fund 0 628,935 0 628,935 628,935 1.64%
HealthCor Offshore II GP 0 628,935 0 628,935 628,935 1.64%
Arthur B Cohen And Joseph Healey
Arthur B Cohen And Joseph Healey
Healthcor Management LP

Page 1 of 15 SEC Filing

SECURITIES & EXCHANGE COMMISSION

Washington, D.C. 20549

———————-

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT

TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED

PURSUANT TO RULE 13d-2

(Amendment No.)*

Clovis Oncology, Inc.

(Name of Issuer)

Common Stock, $.001 Par Value Per Share

(Title of Class of Securities)

189464100

(CUSIP
Number)

March
2, 2016

(Date of Event Which Requires Filing of
this Statement)

Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

(Page 1 of 15 Pages)

—————

*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder
of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Clovis Oncology Inc. (NASDAQ:CLVS)
Trade (NASDAQ:CLVS) Now!
Page 1 of 15

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!